Download
s13075-021-02658-w.pdf 1,48MB
WeightNameValue
1000 Titel
  • First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018
1000 Autor/in
  1. Reiser, Christiane |
  2. Klotsche, Jens |
  3. Hospach, Anton |
  4. Berendes, Rainer |
  5. Schnabel, Anja |
  6. Jansson, Annette F. |
  7. Hufnagel, Markus |
  8. Grösch, Nadine |
  9. Niewerth, Martina |
  10. Minden, Kirsten |
  11. Girschick, Hermann |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-11-08
1000 Erschienen in
1000 Quellenangabe
  • 23(1):281
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13075-021-02658-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573927/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Objective!#!To assess the first-year features of patients with chronic nonbacterial osteomyelitis (CNO).!##!Methods!#!Patients with a diagnosis of CNO, disease duration of under 13 months, and first registration in the German National Pediatric Rheumatologic Database (NPRD) between 2009 and 2018 were included in this cross-sectional analysis.!##!Results!#!Of 774 documented patients, 62.8% were female, and all patients had a median age of 11 years. The most affected clinical sites were the tibia (29.7%), pelvis (28.0%), and femur (27.8%). HLA-B27 was positive in 48 of 314 analyzed patients (15.3%). In 406 patients, an X-ray was performed at the first visit; X-ray results showed osteosclerosis/-lysis in 34.0% and hyperostosis in 14.5% of the patients. MRI scans (focal and whole-body scans) were performed in 648 patients, and 81.5% showed a positive TIRM/STIR signal. A total of 84.7% of the patients were administered nonsteroidal anti-inflammatory drugs, 9.6% were administered oral glucocorticoids, 10.8% were administered disease-modifying anti-rheumatic drugs (DMARDs), and 6.1% were administered bisphosphonates. An evaluation of the patient's questionnaire showed an overall well-being (NRS 0-10) of 2.0. The PedCNO disease 'activity' score revealed a 70% improvement in variables in 43% of patients in the initial 1-year follow-up. Copresentation with diagnostic criteria of pediatric enthesitis-related arthritis was rare.!##!Conclusion!#!To our knowledge, the NPRD cohort seemed to be the largest cohort of children and adolescents suffering from CNO worldwide. Most patients were treated effectively with NSAIDs, and only a small group of patients was administered additional medication. The patient-defined measures of disease activity had a moderate impact on patients' daily lives.!##!Trial registration!#!Not applicable.
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Osteomyelitis/diagnostic imaging [MeSH]
lokal Anti-Inflammatory Agents, Non-Steroidal/therapeutic use [MeSH]
lokal Autoinflammation
lokal Follow-Up Studies [MeSH]
lokal Humans [MeSH]
lokal Chronic nonbacterial multifocal osteomyelitis
lokal Arthritis, Rheumatoid/drug therapy [MeSH]
lokal Cross-Sectional Studies [MeSH]
lokal Osteomyelitis/drug therapy [MeSH]
lokal Diphosphonates/therapeutic use [MeSH]
lokal Chronic nonbacterial osteomyelitis
lokal Pediatric rheumatology
lokal Child [MeSH]
lokal Research Article
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-6817-2798|https://frl.publisso.de/adhoc/uri/S2xvdHNjaGUsIEplbnM=|https://frl.publisso.de/adhoc/uri/SG9zcGFjaCwgQW50b24=|https://frl.publisso.de/adhoc/uri/QmVyZW5kZXMsIFJhaW5lcg==|https://frl.publisso.de/adhoc/uri/U2NobmFiZWwsIEFuamE=|https://frl.publisso.de/adhoc/uri/SmFuc3NvbiwgQW5uZXR0ZSBGLg==|https://frl.publisso.de/adhoc/uri/SHVmbmFnZWwsIE1hcmt1cw==|https://frl.publisso.de/adhoc/uri/R3LDtnNjaCwgTmFkaW5l|https://frl.publisso.de/adhoc/uri/Tmlld2VydGgsIE1hcnRpbmE=|https://frl.publisso.de/adhoc/uri/TWluZGVuLCBLaXJzdGVu|https://frl.publisso.de/adhoc/uri/R2lyc2NoaWNrLCBIZXJtYW5u
1000 Hinweis
  • DeepGreen-ID: ab6518d3afa146aa8e0293375f766682 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6465982.rdf
1000 Erstellt am 2023-11-16T17:51:22.110+0100
1000 Erstellt von 322
1000 beschreibt frl:6465982
1000 Zuletzt bearbeitet 2023-12-01T03:28:01.627+0100
1000 Objekt bearb. Fri Dec 01 03:28:01 CET 2023
1000 Vgl. frl:6465982
1000 Oai Id
  1. oai:frl.publisso.de:frl:6465982 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source